Screen-Triage-Treat cervical cancer screening using self-collected HPV testing for women in HIV care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses an implementation-focused design to test a Screen-Triage-Treat approach for cervical cancer screening within HIV services in Mozambique. It will measure how many women are screened and how many screen-positive individuals receive treatment, while also gathering qualitative data on barriers and facilitators. The analysis will occur under real-world conditions to inform scaling across the country if successful. A mixed-methods approach will combine quantitative screening/treatment data with stakeholder insights. The study is led by Tulane University with NCI/NIH collaboration and will partner with University Eduardo Mondlane in Maputo.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women 25-49 years
* Accessing HIV care and treatment services
* Not being pregnant
* Patients with a cervix

Exclusion Criteria:

* Physical or mental impairment that inhibits participation in the study
* Pregnant women or \<6 weeks post-partum
* Women who have undergone a total hysterectomy with removal of the cervix

Where it's running

• University Eduardo Mondlane (UEM)
  Maputo, Mozambique Recruiting

Study contacts

• Principal investigator: D. Troy Moon, MD, MPH — Tulane University
• Study coordinator: Kathryn Kampa, MPH
• Email: kkampa@tulane.edu
• Phone: 651-983-1076

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Enhanced support for Connected MOM Plus in pregnancy and postpartum care

  A program that tests whether extra coaching helps pregnant people use Connected MOM Plus more, especially if they have limited access to care.

  Recruiting Tulane University · New Orleans, Louisiana · NCT07691541

• Continuous glucose monitoring for adults with type 2 diabetes in underserved communities

  This project will test whether giving continuous glucose monitors to uninsured or Medicaid-insured adults with type 2 diabetes who take daily insulin helps them manage their blood sugar better than standard fingerstick monitoring.

  Recruiting Tulane University · New Orleans, Louisiana · NCT07135531

• Improving diabetes care by treating insomnia with CBT-I

  A pilot test to see if a 6-week CBT-I program added to usual diabetes care helps sleep and diabetes control for adults with type 2 diabetes and insomnia in an FQHC setting.

  Recruiting Tulane University · Zachary, Louisiana · NCT07062406

• Weight loss intervention for underserved communities in Louisiana

  This study is testing a new weight loss program for low-income adults in Louisiana to see if it helps them lose weight and improve their health compared to regular care.

  Recruiting at 18 sites Tulane University · Avondale, Louisiana and 17 other locations · NCT06835686

• Free testing and treatment program for chlamydia, gonorrhea, syphilis, and HIV

  This program offers free testing for four STIs and provides counseling and no-cost expedited treatment options for Black people aged 15–26 who live or spend most of their time in Orleans Parish.

  Recruiting Tulane University · New Orleans, Louisiana · NCT06428643

• Single-dose secnidazole versus multi-dose metronidazole for treating Trichomonas vaginalis

  This compares a single-dose secnidazole pill with multi-dose metronidazole to see if secnidazole works better and costs less for treating Trichomonas in adults.

  Recruiting at 3 sites Phase 4 Tulane University · Birmingham, Alabama and 3 other locations · NCT06261840

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.